Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin for Acute Coronary Syndromes: A Canadian Hospital Perspective

Robert M. Balen,Carlo A. Marra,Peter J. Zed,Marc Cohen,Luciana Frighetto

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin for Acute Coronary Syndromes: A Canadian Hospital Perspective

1999

Robert M. Balen
Carlo A. Marra
Peter J. Zed
Marc Cohen
Luciana Frighetto

Objective: To determine the cost effectiveness of enoxaparin therapy versus unfractionated heparin (UFH) therapy for patients with unstable coronary artery disease from the perspective of a Canadian hospital.

Keywords:

Pharmacoeconomics
Physical therapy
Heparin
Cost-effectiveness analysis
Unstable angina
Myocardial infarction
Coronary artery disease
Enoxaparin sodium
Acute coronary syndrome
Medicine
Intensive care medicine
cost effectiveness

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations